1. Global Injectable Drug Delivery Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

2. Global Injectable Drug Delivery Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 The Global Injectable Drug Delivery market is accounted for $348.64 billion in 2015 and is expected to reach $866.31 billion by 2022 growing at a CAGR of 13.9%. Rising incidences of chronic diseases, technological advancements and increase in demand for self injection devices are some of the factors proliferating market demand. However, factors such as needle-stick injuries and lack of access to or failure to use appropriate personal protective equipment are some factors inhibiting the market. Browse the report: http://www.orbisresearch.com/reports/index/injectable-drug-delivery-global-market-outlook- 2016-2022 Oncology and Hormonal disorder segment among therapeutic applications is expected to dominate the market owing to the rising number of patients suffering from diabetes and oncologic disorders. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

3. Global Injectable Drug Delivery Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022 Moreover, self-injection device segment in product type is estimated to be the fastest growing segment on account of growing geriatric people coupled with diabetic patients. North American market is estimated to be the dominant among others attributed to its huge patient base and healthcare sector. Asia Pacific is expected to be the fastest growing market on account of its emerging healthcare sector. Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/223186 Some of the key players of the Injectable Drug Delivery market include Alkermes PLC, Baxter International, Inc., Becton, Dickinson and Company, Elcam Medical, ELI Lilly and Company, Gerresheimer AG, Novo Nordisk, Pfizer, Inc., Sandoz, Schott AG, Terumo Corporation and Teva Pharmaceutical Industries Ltd. Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com

4. About Us: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors accross the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients. Contact Information: 4144N Central Expressway, Suite 600, Dallas, Texas - 75204, U.S.A. Phone No.: +1 (214) 884-6817 enquiry@orbisresearch.com sales@orbisresearch.com Phone No.: +1 (214) 884-6817 Email id: sales@orbisresearch.com Global Injectable Drug Delivery Market 2017 Analysis, Segmentation, Competitors Analysis, Trends and Forecast by 2022